From October 1, 2023 to March 31, 2024, the company has repurchased 35,851,329 shares, representing 4.74% for CNY 222.07 million. With this, the company has completed the repurchase of 49,999,929 shares, representing 6.59% for CNY 322.09 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.56 CNY | +1.23% | +2.02% | -4.93% |
1st Jan change | Capi. | |
---|---|---|
-4.93% | 653M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B | |
-2.27% | 4.81B |
- Stock Market
- Equities
- 600351 Stock
- News Yabao Pharmaceutical Group Co., Ltd
- Tranche Update on Yabao Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on May 9, 2023.